Standard BioTools Inc (LAB)
1.62
+0.01
(+0.62%)
USD |
NASDAQ |
Nov 21, 16:00
1.64
+0.02
(+1.23%)
After-Hours: 20:00
Standard BioTools Enterprise Value: 291.94M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 291.94M |
| November 20, 2024 | 288.22M |
| November 19, 2024 | 250.99M |
| November 18, 2024 | 247.27M |
| November 15, 2024 | 277.05M |
| November 14, 2024 | 321.72M |
| November 13, 2024 | 373.84M |
| November 12, 2024 | 452.01M |
| November 11, 2024 | 519.02M |
| November 08, 2024 | 489.24M |
| November 07, 2024 | 500.41M |
| November 06, 2024 | 530.19M |
| November 05, 2024 | 474.35M |
| November 04, 2024 | 470.63M |
| November 01, 2024 | 429.68M |
| October 31, 2024 | 418.51M |
| October 30, 2024 | 388.73M |
| October 29, 2024 | 340.34M |
| October 28, 2024 | 321.73M |
| October 25, 2024 | 314.28M |
| October 24, 2024 | 332.89M |
| October 23, 2024 | 351.51M |
| October 22, 2024 | 373.84M |
| October 21, 2024 | 388.73M |
| October 18, 2024 | 396.18M |
| Date | Value |
|---|---|
| October 17, 2024 | 358.95M |
| October 16, 2024 | 392.46M |
| October 15, 2024 | 392.46M |
| October 14, 2024 | 392.46M |
| October 11, 2024 | 392.46M |
| October 10, 2024 | 347.78M |
| October 09, 2024 | 347.78M |
| October 08, 2024 | 358.95M |
| October 07, 2024 | 366.40M |
| October 04, 2024 | 377.56M |
| October 03, 2024 | 362.67M |
| October 02, 2024 | 381.29M |
| October 01, 2024 | 381.29M |
| September 30, 2024 | 407.35M |
| September 27, 2024 | 372.99M |
| September 26, 2024 | 365.56M |
| September 25, 2024 | 339.58M |
| September 24, 2024 | 391.54M |
| September 23, 2024 | 354.43M |
| September 20, 2024 | 406.39M |
| September 19, 2024 | 443.50M |
| September 18, 2024 | 413.81M |
| September 17, 2024 | 402.68M |
| September 16, 2024 | 436.08M |
| September 13, 2024 | 424.95M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-57.79M
Minimum
Sep 29 2022
985.09M
Maximum
Mar 28 2024
294.67M
Average
308.76M
Median
Jun 03 2020
Enterprise Value Benchmarks
| Ainos Inc | 13.27M |
| Zomedica Corp | 51.69M |
| LENSAR Inc | 68.45M |
| Intelligent Bio Solutions Inc | 3.549M |
| Adagio Medical Holdings Inc | 20.24M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -26.94M |
| Revenue (Quarterly) | 44.97M |
| Total Expenses (Quarterly) | 69.27M |
| EPS Diluted (Quarterly) | -0.07 |
| Gross Profit Margin (Quarterly) | 51.73% |
| Profit Margin (Quarterly) | -59.90% |
| Earnings Yield | -43.83% |
| Normalized Earnings Yield | -37.38 |